India got it earlier this year, and Canada approved it last month. But when is the United States going to get a generic version of Ozempic?

In Canada, apo-semaglutide is indicated as a once-weekly treatment for adults with Type 2 diabetes to improve glycemic control alongside diet and exercise.

Forever chemicals, generic drugs and the hidden calories sabotaging your diet. Here are today's health headlines.

By partnering with a UN-backed body, Roche has enabled companies to make the medicine for supply in 129 countries.

Roche has signed a voluntary license agreement providing its popular influenza antiviral drug Xofluza (baloxavir marboxil) for generic drugmakers to copy in 129 developing countries.  | Roche has signed a voluntary license agreement providing its popular influenza antiviral drug Xofluza for generic drugmakers to copy in 129 developing countries.

Every week through October, we are examining the medical, business and cultural systems that contribute to the dichotomy that is the American health care system — a system that benefits some but costs all of us. Today we're looking at generic drugs.

TORONTO — Two generic versions of Ozempic are set to start arriving in Canadian pharmacies this week, which means patients who use the drug to treat diabetes or for weight loss may have more options for a fraction of the cost.

Canada has become only the second country in the world to approve a generic form of the blockbuster drug Ozempic (semaglutide), made possible after its manufacturer, Novo Nordisk, did not pay a $C250 annual fee.